PUBLICATION

Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis

Authors
García-Castillo, J., Alcaraz-Pérez, F., Martínez-Balsalobre, E., García-Moreno, D., Rossmann, M.P., Fernández-Lajarín, M., Bernabé-García, M., Pérez-Oliva, A.B., Rodríguez-Cortez, V.C., Bueno, C., Adatto, I., Agarwal, S., Menéndez, P., Zon, L.I., Mulero, V., Cayuela, M.L.
ID
ZDB-PUB-210807-2
Date
2021
Source
Proceedings of the National Academy of Sciences of the United States of America   118(32): (Journal)
Registered Authors
Adatto, Isaac, Mulero, Victor, Zon, Leonard I.
Keywords
dyskeratosis congenita, myelopoiesis, telomerase RNA component, zebrafish
MeSH Terms
  • Mutation
  • Zebrafish/genetics
  • Induced Pluripotent Stem Cells/pathology
  • Animals, Genetically Modified
  • Gene Expression Regulation
  • Myelopoiesis/genetics
  • Myelopoiesis/physiology*
  • Larva/genetics
  • Promoter Regions, Genetic
  • Cells, Cultured
  • Animals
  • Humans
  • RNA/genetics
  • RNA/metabolism*
  • Protein Domains
  • Zebrafish Proteins/genetics
  • RNA Polymerase II/genetics*
  • RNA Polymerase II/metabolism
  • Binding Sites
  • Telomerase/genetics
  • Telomerase/metabolism*
  • Dyskeratosis Congenita/genetics*
  • Dyskeratosis Congenita/pathology
(all 23)
PubMed
34353901 Full text @ Proc. Natl. Acad. Sci. USA
Abstract
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure and cancer predisposition syndrome caused by mutations in telomerase or telomeric proteins. Here, we report that zebrafish telomerase RNA (terc) binds to specific DNA sequences of master myeloid genes and controls their expression by recruiting RNA Polymerase II (Pol II). Zebrafish terc harboring the CR4-CR5 domain mutation found in DC patients hardly interacted with Pol II and failed to regulate myeloid gene expression in vivo and to increase their transcription rates in vitro. Similarly, TERC regulated myeloid gene expression and Pol II promoter occupancy in human myeloid progenitor cells. Strikingly, induced pluripotent stem cells derived from DC patients with a TERC mutation in the CR4-CR5 domain showed impaired myelopoiesis, while those with mutated telomerase catalytic subunit differentiated normally. Our findings show that TERC acts as a transcription factor, revealing a target for therapeutic intervention in DC patients.
Genes / Markers
Figures
Figure Gallery (7 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
i114TgTransgenic Insertion
    zf3577TgTransgenic Insertion
      zf3578
        Small Deletion
        1 - 3 of 3
        Show
        Human Disease / Model
        Sequence Targeting Reagents
        Target Reagent Reagent Type
        gata1aMO2-gata1aMRPHLNO
        linc-trMO1-linc-trMRPHLNO
        linc-trMO2-linc-trMRPHLNO
        linc-trMO3-linc-trMRPHLNO
        1 - 4 of 4
        Show
        Fish
        Antibodies
        No data available
        Orthology
        No data available
        Engineered Foreign Genes
        Marker Marker Type Name
        EGFPEFGEGFP
        GFPEFGGFP
        1 - 2 of 2
        Show
        Mapping
        No data available